181259-09-6

Basic information

• Product Name: 8-Hydroxy-4-[(methyl-phenethyl-carbamoyl)-methyl]-naphthalene-2-carboxylic acid methyl ester
• Synonyms: 8-Hydroxy-4-[(methyl-phenethyl-carbamoyl)-methyl]-naphthalene-2-carboxylic acid methyl ester
• CAS NO: 181259-09-6
• Molecular Weight: 377.44
• Mol File: 181259-09-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 8-Hydroxy-4-[(methyl-phenethyl-carbamoyl)-methyl]-naphthalene-2-carboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 8-Hydroxy-4-[(methyl-phenethyl-carbamoyl)-methyl]-naphthalene-2-carboxylic acid methyl ester(181259-09-6)
• EPA Substance Registry System: 8-Hydroxy-4-[(methyl-phenethyl-carbamoyl)-methyl]-naphthalene-2-carboxylic acid methyl ester(181259-09-6)

Safety Data

• Hazardous Substances Data: 181259-09-6(Hazardous Substances Data)

Upstream product

• 163685-19-6 Methyl 4-<2--2-oxoethyl>-8-(phenylmethoxy)-2-naphthalenecarboxylate 
• 144003-47-4 Methyl 8-(phenylmethoxy)-4-<<(trifluoromethyl)sulfonyl>oxy>-2-naphthalenecarboxylate 
• 144003-50-9 3-carbomethoxy-5-(phenylmethoxy)-1-naphthaleneacetic acid 
• 144003-45-2 methyl 4-acetoxy-8-(phenylmethoxy)-2-naphthalenecarboxylate 
• 144003-49-6 methyl 4-(2-hydroxyethyl)-8-(phenylmethoxy)-2-naphthalenecarboxylate 
• 144003-46-3 methyl 4-hydroxy-8-(phenylmethoxy)-2-naphthalenecarboxylate 
• 144003-48-5 methyl 8-(phenylmethoxy)-4-vinyl-2-naphthalenecarboxylate 

Downstream Products

• 181259-10-9 8-Methoxy-4-[(methyl-phenethyl-carbamoyl)-methyl]-naphthalene-2-carboxylic acid methyl ester 
• 181259-11-0 4-[(Methyl-phenethyl-carbamoyl)-methyl]-8-pentyloxy-naphthalene-2-carboxylic acid methyl ester 

Relevant articles and documents

Structure-activity relationships study of two series of leukotriene B4 antagonists: Novel indolyl and naphthyl compounds substituted with a 2- [methyl(2-phenethyl)amino]-2-oxoethyl side chain

N-Methyl-N-phenethylphenylacetamide has been reported to be a key binding domain to LTB4 receptors. Here we describe the synthesis and structure-activity relationship (SAR) studies of two new series of LTB4 receptor antagonists in wh